Showing results (1641-1650 of 4,565) with videos related to

Sort By:
Pageof 457
Advances in Therapy|August 23, 2011
Tafluprost: a novel prostaglandin analog for treatment of glaucomaMina B Pantcheva, Leonard K Seibold, Nida S Awadallah, et al.
Advances in Therapy|August 3, 2011
What is the role of direct renin inhibitors in the treatment of the hypertensive diabetic patient?Alejandro de la Sierra, Jorge Salazar
Advances in Therapy|January 25, 2012
Amlodipine/valsartan single-pill combination: a prospective, observational evaluation of the real-life safety and effectiveness in the routine treatment of hypertensionYuri Karpov, Neelesh Dongre, Alexey Vigdorchik, et al.
Advances in Therapy|January 25, 2012
Lack of pharmacokinetic interactions between dapagliflozin and simvastatin, valsartan, warfarin, or digoxinSreeneeranj Kasichayanula, Ming Chang, Xiaoni Liu, et al.
Advances in Therapy|March 14, 2012
Cost per treated patient for etanercept, adalimumab, and infliximab across adult indications: a claims analysisMachaon M K Bonafede, Shravanthi R Gandra, Crystal Watson, et al.
Advances in Therapy|November 10, 2011
An overview of letrozole in postmenopausal women with hormone-responsive breast cancerAgustí Barnadas, Laura G Estévez, Ana Lluch-Hernández, et al.
Advances in Therapy|November 23, 2011
Multiple myeloma with extramedullary diseaseAlbert Oriol
Advances in Therapy|July 2, 2017
Intracameral Dexamethasone Injection as Adjuvant Therapy in Endothelial Immune Reaction After Penetrating and Posterior Lamellar Keratoplasty: A Retrospective Clinical ObservationMiltiadis Fiorentzis, Arne Viestenz, Anja Viestenz, et al.
Advances in Therapy|July 9, 2017
Prevalence of Lower Urinary Tract Symptoms in China, Taiwan, and South Korea: Results from a Cross-Sectional, Population-Based StudyChristopher Chapple, David Castro-Diaz, Yao-Chi Chuang, et al.
Advances in Therapy|July 9, 2017
Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical TrialArrigo F G Cicero, Federica Fogacci, Marilisa Bove, et al.
Pageof 457